Skip to main content
Premium Trial:

Request an Annual Quote

Accelrys Q2 Revenues Rise 31 Percent, Net Loss Drops 40 Percent

NEW YORK, Aug. 5 (GenomeWeb News) - Accelrys yesterday reported increased revenues and a narrowed net loss for the second quarter of 2005.

 

Revenues for the quarter were $18.6 million, up 31 percent from $14.2 million during the same period last year. This quarter's revenues included deferred revenue from the company's switch to subscription accounting.

 

Product development costs increased to $4.9 million, up from $4.1 million during the year-ago quarter.

 

Accelrys' net loss fell 40 percent to $3.7 million, or $.14 per share, from $6.2 million, or $.25 per share, for the second quarter of last year. Last year's loss included $1.1 million from discontinued operations.

 

As of June 30, Acclerys had $56.3 million in cash, restricted cash, cash equivalents, and marketable securities.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.